Optimal Thiotepa Exposure Is Associated with Improved Rejection and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta-T-cell/CD19-Depleted Haploidentical HCT for Hematologic Malignancy

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Christopher C. Dvorak, Willem Collier, Soohee Cho, Lucia Holbrook-Brown, Julie‐An Talano, Anant Vatsayan, Nahal Rose Lalefar, Eric Jon Anderson, Timothy S. Olson, Christine S. Higham, Paibel Ixia Aguayo-Hiraldo, Candelaria Deimundo Roura
+8 more Neena Kapoor, Julie Waldhart, Maryanne C Odinakachukwu, David Alex Jacobsohn, Ron J. Keizer, Jordan Brooks, Michael A. Pulsipher, Janel Renee Long-Boyle
DOI: 10.1016/j.jtct.2025.12.859
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Blood transfusion and management

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S570–S571
Publication date
1 February 2026
Language
EN